These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3554549)

  • 1. [The prostacyclin-thromboxane A2 system in ischemic heart disease].
    Pavlov NA
    Sov Med; 1987; (2):36-9. PubMed ID: 3554549
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane and prostacyclin in disease: a review.
    Halushka PV; Dollery CT; MacDermot J
    Q J Med; 1983; 52(208):461-70. PubMed ID: 6361838
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stenocardia. Thromboxane A2 and prostacyclin].
    Panchenko EP
    Kardiologiia; 1986 Jul; 26(7):109-16. PubMed ID: 3093749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostanoids and coronary circulation].
    Tada M; Kuzuya T; Hoshida S
    Nihon Rinsho; 1982; 40(11):2432-8. PubMed ID: 6759703
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered metabolism of thromboxane A2 and prostacyclin in the pathogenesis of coronary vasospasm and thrombosis.
    Tada M; Kuzuya T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():481-4. PubMed ID: 2936148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neurohumoral and functional determinants of destabilization in patients with acute forms of ischemic heart disease].
    Tashchuk VK; Savitskiĭ SIu; Shumakov VA; Popova LI; Malinovskaia IE; Reĭko MN
    Vrach Delo; 1991 Jun; (6):28-30. PubMed ID: 1832506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
    Moncada S; Vane JR
    Drug Ther; 1982; ():37-65. PubMed ID: 7049651
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thromboxane A2-PGI2 balance and its clinical significance].
    Zhou YC; Wong XZ
    Zhonghua Nei Ke Za Zhi; 1987 Jan; 26(1):49-52. PubMed ID: 3297553
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic fate of thromboxane A2 and prostacyclin.
    Roberts LJ; Brash AR; Oates JA
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():211-25. PubMed ID: 6216783
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostacyclin and thromboxane in obstetrics].
    Liu LL
    Zhonghua Fu Chan Ke Za Zhi; 1988 Mar; 23(2):110-2. PubMed ID: 3056666
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostacyclin and thromboxane in thrombosing atherosclerotic diseases].
    Viinikka L
    Duodecim; 1981; 97(13):925-7. PubMed ID: 7032876
    [No Abstract]   [Full Text] [Related]  

  • 13. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.
    Dogné JM; Hanson J; Pratico D
    Trends Pharmacol Sci; 2005 Dec; 26(12):639-44. PubMed ID: 16243403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
    Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostaglandins and kidney functions].
    Okahara T
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):915-6. PubMed ID: 6363777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
    Berdeaux A; Giudicelli JF
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of prostacyclin in thromboresistance].
    Kume S; Higashihara M; Tanabe A; Takahata K
    Kokyu To Junkan; 1985 Jul; 33(7):877-81. PubMed ID: 2997895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.